Ferric Maltol Patent Expiration
Ferric Maltol is used for treating iron deficiency. It was first introduced by Shield Tx Uk Ltd
Ferric Maltol Patents
Given below is the list of patents protecting Ferric Maltol, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Accrufer | US9802973 | Crystalline forms of ferric maltol | Oct 23, 2035 | Shield Tx |
| Accrufer | US10179120 | Dosage regimen of ferric trimaltol | Jan 06, 2035 | Shield Tx |
| Accrufer | US9248148 | Mono (iron hydroxypyrone) and combination (iron hydroxypyrone and GI inflammation inhibiting agents) compositions for anaemia or H. pylori infections | Mar 29, 2031 | Shield Tx |
Ferric Maltol's Family Patents
Explore Our Curated Drug Screens
Clinical Trials
Recent Clinical Trials on Ferric Maltol:
Sometimes companies keep conducting clinical trials even after the drug's approval to discover new formulations, methods of use, or new treatment indications, so they could file for additional patents or receive regulatory exclusivity extensions, such as pediatric exclusivity, potentially delaying generic competition. Based on these recent clinical trials, generic companies need to consider the potential for new intellectual property or regulatory hurdles. These strategic moves by the drug owner might delay generic substitution or lead to additional sales of the brand drug, even after patent expiry.
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel Disease | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | NA |
COMPLETED
(Jul 1, 2026)
| PHASE3 |